Impact of COVID-19 on assisted reproductive technologies and its multifacet influence on global bioeconomy

Several nations of the world have issued instructions such as travel restrictions, border closure, and lockdown, plus other directives proposing that non-essential care must be withdrawn including assisted reproductive services, in an attempt to identify resources to ascertain the dissemination of SARS-CoV-2. This has led to massive shortage in medical supplies, inappropriate service delivery, hike in price, decrease in staff work load, salary cut, decrease in the utilization of qualitative maternal, and reproductive health-care services thereby creating high risk on reproductive health and global bioeconomy. The search for right candidate for the management of coronavirus disease 2019 and several reproductive health challenges begins with the screening of natural products to identify novel active constituent. Moreover, there is need to pay more attention to crucial phytochemical, bioactive fractions, phytoanalysis, and phytopharmacological investigation for effective drug discovery most especially these bioresources from beneficial microorganisms, plants, and ocean deposits that could help in mitigation of SARS-CoV-2 and reproduction health challenges through chemoinformatics, informatics, synthetic biology, nanotechnology, and metabolomics hence boosting the global economy.